Neuberger Berman Canada’s Eli Lilly LLY Stock Holding History

Neuberger Berman Canada’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$221K	Buy	+2,579	New	+$212K	0.04%	304
2015 Q1	–	Sell	-4,450	Closed	-$307K	–	237
2014 Q4	$307K	Buy	+4,450	New	+$300K	0.05%	259
2014 Q2	–	Sell	-7,800	Closed	-$459K	–	275
2014 Q1	$459K	Sell	7,800 -47,300	-86%	-$2.64M	0.1%	219
2013 Q4	$2.81M	Buy	+55,100	New	+$2.76M	0.66%	32

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Neuberger Berman Canada's LLY Position: Q3 2017 in Review

Neuberger Berman Canada opened a new position in Eli Lilly (LLY) in Q3 2017: 2,579 shares worth $221K. The stake represents 0.04% of the portfolio and ranks #304 among its holdings. This is a return to the name: Neuberger Berman Canada previously reported a position in LLY as recently as Q4 2014.

Neuberger Berman Canada first reported a position in LLY in Q4 2013 and has held it in 4 quarters since. The position peaked at $2.81M in Q4 2013. 1,228 funds tracked by Wall St. Rank hold LLY as of Q3 2017.

Neuberger Berman Canada held 2,579 shares of Eli Lilly worth $221K as of Q3 2017.
Eli Lilly was a new Neuberger Berman Canada position in Q3 2017.
Eli Lilly made up 0.04% of Neuberger Berman Canada's portfolio in Q3 2017, its #304 holding.
Neuberger Berman Canada first reported a position in Eli Lilly in Q4 2013 and has held it in 4 quarters since.
Neuberger Berman Canada's Eli Lilly position peaked at $2.81M in Q4 2013.
1,228 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2017.

Based on Neuberger Berman Canada's 13F filing for Q3 2017, filed 3 Nov 2017.